DOI QR코드

DOI QR Code

Characterization of CTL Clones Specific for Single Antigen, H60 Minor Histocompatibility Antigen

  • Jeon, Ji-Yeong (Department of Biomedical Sciences, Seoul National University College of Medicine) ;
  • Jung, Kyung-Min (Graduate Program of Immunology, Seoul National University College of Medicine) ;
  • Chang, Jun (Division of Life and Pharmaceutical Sciences, Ewha Womans University) ;
  • Choi, Eun-Young (Department of Biomedical Sciences, Seoul National University College of Medicine)
  • Received : 2011.03.09
  • Accepted : 2011.03.17
  • Published : 2011.04.30

Abstract

Background: Disparities of Minor H antigens can induce graft rejection after MHC-matched transplantation. H60 has been characterized as a dominant antigen expressed on hematopoietic cells and considered to be an ideal model antigen for study on graft-versus-leukemia effect. Methods: Splenocytes from C57BL/6 mice immunized with H60 congenic splenocytes were used for establishment of H60-specific CTL clones. Then the clones were characterized for proliferation capacity and cytotoxicity after stimulation with H60. Clone #14, #15, and #23 were tested for the TCR binding avidity to H60-peptide/$H-2K^b$ and analyzed for TCR sequences. Results: H60-specific CTL clones showed different levels of proliferation capacity and cytotoxic activity to H60-stimulation. Clones #14, #15, and #23 showed high proliferation activity, high cytotoxicity, and low activities on both aspects, respectively, and have TCRs with different binding avidities to H60-peptide/$H-2K^b$ with $t_{1/2}$ values of 4.87, 6.92, and 13.03 minutes, respectively. The TCR usages were $V{\alpha}12D-3-01+J{\alpha}11-01$ and $V{\beta}12-1-01+D{\beta}1-01+J2-7-01$ for clone #14, $V{\alpha}13D-1-02+J{\alpha}34-02$ and $V{\beta}13-1-02+D{\beta}2-01+J{\beta}2-7-01$ for clone #15, and $V{\alpha}16D+J{\alpha}45-01$ and $V{\beta}12-1-01+D{\beta}1-01+J{\beta}2-5-01$ for clone #23. Conclusion: The results will be useful for modeling GVL and generation TCR transgenic mouse.

Keywords

References

  1. Simpson E: Minor histocompatibility antigens. Immunol Lett 29;9-14, 1991 https://doi.org/10.1016/0165-2478(91)90192-D
  2. Simpson E, Roopenian D: Minor histocompatibility antigens. Curr Opin Immunol 9;655-661, 1997 https://doi.org/10.1016/S0952-7915(97)80045-3
  3. Wettstein PJ: Immunodominance in the T-cell response to multiple non-H-2 histocompatibility antigens. II. Observation of a hierarchy among dominant antigens. Immunogenetics 24;24-31, 1986 https://doi.org/10.1007/BF00372294
  4. Choi EY, Yoshimura Y, Christianson GJ, Sproule TJ, Malarkannan S, Shastri N, Joyce S, Roopenian DC: Quantitative analysis of the immune response to mouse non-MHC transplantation antigens in vivo: the H60 histocompatibility antigen dominates over all others. J Immunol 166;4370-4379, 2001
  5. Malarkannan S, Shih PP, Eden PA, Horng T, Zuberi AR, Christianson G, Roopenian D, Shastri N: The molecular and functional characterization of a dominant minor H antigen, H60. J Immunol 161;3501-3509, 1998
  6. Korngold R: Lethal graft-versus-host disease in mice directed to multiple minor histocompatibility antigens: features of CD8+ and CD4+ T cell responses. Bone Marrow Transplant 9;355-364, 1992
  7. van Lochem E, de Gast B, Goulmy E: In vitro separation of host specific graft-versus-host and graft-versus-leukemia cytotoxic T cell activities. Bone Marrow Transplant 10;181-183, 1992
  8. Goulmy E: Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunol Rev 157;125-140, 1997 https://doi.org/10.1111/j.1600-065X.1997.tb00978.x
  9. Choi JH, Yoon H, Min CK, Choi EY: Effects of Pre-conditioning Dose on the Immune Kinetics and Cytokine Production in the Leukocytes Infiltrating GVHD Tissues after MHC-matched Transplantation. Immune Netw 11;68-78, 2011 https://doi.org/10.4110/in.2011.11.1.68
  10. Ryu SJ, Jung KM, Yoo HS, Kim TW, Kim S, Chang J, Choi EY: Cognate CD4 help is essential for the reactivation and expansion of CD8 memory T cells directed against the hematopoietic cell-specific dominant minor histocompatibility antigen, H60. Blood 113;4273-4280, 2009 https://doi.org/10.1182/blood-2008-09-181263
  11. Choi EY, Christianson GJ, Yoshimura Y, Sproule TJ, Jung N, Joyce S, Roopenian DC: Immunodominance of H60 is caused by an abnormally high precursor T cell pool directed against its unique minor histocompatibility antigen peptide. Immunity 17;593-603, 2002 https://doi.org/10.1016/S1074-7613(02)00428-4
  12. Choi JH, Ryu SJ, Jung KM, Kim S, Chang J, Kim TW, Choi EY: TCR diversity of H60-specific CD8 T cells during the response evolution and influence of CD4 help. Transplantation 87;1609-1616, 2009 https://doi.org/10.1097/TP.0b013e3181a52dc4

Cited by

  1. A single-amino-acid variant of the H60 CD8 epitope generates specific immunity with diverse TCR recruitment vol.33, pp.4, 2012, https://doi.org/10.1007/s10059-012-0008-3
  2. Escape from thymic deletion and anti-leukemic effects of T cells specific for hematopoietic cell-restricted antigen vol.9, pp.1, 2018, https://doi.org/10.1038/s41467-017-02665-z
  3. H60: A Unique Murine Hematopoietic Cell-Restricted Minor Histocompatibility Antigen for Graft-versus-Leukemia Effect vol.11, pp.None, 2011, https://doi.org/10.3389/fimmu.2020.01163